By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Atara Biotherapeutics (ATRA) Receives Positive Health Canada Regulatory Feedback For ATA129 9/11/2017 11:01:24 AM
Atara Biotherapeutics (ATRA) Receives FDA Orphan Drug Designation For ATA230 9/5/2017 10:36:41 AM
Atara Biotherapeutics (ATRA) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 8/24/2017 6:13:48 AM
Atara Biotherapeutics (ATRA) Expands Leadership Team With The Appointment Of Dr. Kanya Rajangam As Senior Vice President And Chief Medical Officer 8/22/2017 10:30:52 AM
Atara Biotherapeutics (ATRA) Announces Second Quarter 2017 Financial Results And Recent Highlights 8/8/2017 1:39:06 PM
Atara Biotherapeutics (ATRA) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 5/11/2017 11:53:15 AM
Atara Biotherapeutics (ATRA) Enhances Commercial Expertise With The Appointment Of Dr. Derrell Porter To The Executive Leadership Team 5/10/2017 10:02:49 AM
Atara Biotherapeutics (ATRA) Announces First Quarter 2017 Financial Results And Recent Highlights 5/5/2017 11:39:15 AM
Atara Biotherapeutics (ATRA) Announces Positive Interim Results from Ongoing Phase I Trial of the Autologous Version of ATA188 in Patients with Primary and Secondary Progressive Multiple Sclerosis (MS) at the American Academy of Neurology Annual Meeting 2017 4/21/2017 8:54:50 AM
Atara Biotherapeutics (ATRA) Announces Collaboration With Merck & Co. (MRK) to Evaluate KEYTRUDA┬« (Pembrolizumab) In Combination With ATA129 In Nasopharyngeal Carcinoma (NPC) 4/21/2017 8:03:12 AM
123456
//-->